Artículos por temáticas
En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.
Tema
2012
4261 ARTíCULOS , VIENDO DEL 1 AL 15
Clozapine Therapy and CYP Genotype
Dean L, Kane M.
2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.
0
0
0
Clozapine Therapy and CYP Genotype
Dean L, Kane M.
2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.
0
0
0
Clozapine Therapy and CYP Genotype
Dean L, Kane M.
2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.
0
0
0
Aripiprazole Therapy and CYP2D6 Genotype
Dean L, Kane M.
2016 Sep 22 [updated 2021 Feb 10]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.
0
0
0
2020 Jul 18. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
0
0
0
Atomoxetine Therapy and CYP2D6 Genotype
Dean L.
2015 Sep 10 [updated 2020 Jun 29]. In: Pratt VM, McLeod HL, Rubinstein WS, Scott SA, Dean LC, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.
0
0
0
Drug-induced movement disorders: emergencies and management.
Robottom BJ, Shulman LM, Weiner WJ.
Neurol Clin. 2012 Feb;30(1):309-20, x. doi: 10.1016/j.ncl.2011.09.007. Review.
0
0
0
Functional brain networks and abnormal connectivity in the movement disorders.
Poston KL, Eidelberg D.
Neuroimage. 2012 Oct 1;62(4):2261-70. doi: 10.1016/j.neuroimage.2011.12.021. Review.
0
0
0
Sleep-related movement disorders.
Merlino G, Gigli GL.
Neurol Sci. 2012 Jun;33(3):491-513. doi: 10.1007/s10072-011-0905-9. Review.
0
0
0
Psychogenic movement disorders in children: characteristics and predictors of outcome.
Faust J, Soman TB.
J Child Neurol. 2012 May;27(5):610-4. doi: 10.1177/0883073811422753.
0
0
0
Effectiveness of an inpatient movement disorders program for patients with atypical parkinsonism.
Hohler AD, Tsao JM, Katz DI, Dipiero TJ, Hehl CL, Leonard A, Allen V, Gardner M, Phenix H, Saint-Hilaire M, Ellis T.
Parkinsons Dis. 2012;2012:871974. doi: 10.1155/2012/871974.
0
0
0
Kulisevsky J, Poyurovsky M.
Eur Neurol. 2012;67(1):4-11. doi: 10.1159/000331768. Review.
0
0
0
Movement disorders in patients with diabetes mellitus.
Jagota P, Bhidayasiri R, Lang AE.
J Neurol Sci. 2012 Mar 15;314(1-2):5-11. doi: 10.1016/j.jns.2011.10.033. Review.
0
0
0
Occurrence of eye movement disorders in motor neuron disease.
Beaufils E, Corcia P, de Toffol B, Praline J.
Amyotroph Lateral Scler. 2012 Jan;13(1):84-6. doi: 10.3109/17482968.2011.580848.
0
0
0
Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol.
Czarnecki K, Thompson JM, Seime R, Geda YE, Duffy JR, Ahlskog JE.
Parkinsonism Relat Disord. 2012 Mar;18(3):247-51. doi: 10.1016/j.parkreldis.2011.10.011.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
